VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+11.55%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$208M
AUM Growth
+$208M
Cap. Flow
-$144K
Cap. Flow %
-0.07%
Top 10 Hldgs %
85.99%
Holding
26
New
2
Increased
2
Reduced
–
Closed
4

Top Buys

1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$8.24M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$2.22M
3
KALV icon
KalVista Pharmaceuticals
KALV
$1.32M
4
OCRX
Ocera Therapeutics, Inc.
OCRX
$272K

Top Sells

1
RGNX icon
Regenxbio
RGNX
$4.66M
2
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$3.67M
3
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$3.4M
4
LRMR icon
Larimar Therapeutics
LRMR
$468K

Sector Composition

1 Healthcare 89.81%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$49.4M 23.71% 1,035,657 – –
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$1.74B
$38.4M 18.43% 6,071,142 +350,000 +6% +$2.22M
PDSB icon
3
PDS Biotechnology
PDSB
$57.8M
$24.2M 11.59% 1,933,582 – –
ASND icon
4
Ascendis Pharma
ASND
$11.8B
$14.6M 7% 721,152 – –
BOLD
5
DELISTED
Audentes Therapeutics, Inc
BOLD
$8.25M 3.96% 458,882 – –
RARX
6
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$8.24M 3.95% +542,500 New +$8.24M
CTMX icon
7
CytomX Therapeutics
CTMX
$336M
$6.35M 3.05% 577,831 – –
CLCD
8
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$5.79M 2.78% 159,110 – –
SIOX
9
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$5.34M 2.56% 429,590 – –
HRTX icon
10
Heron Therapeutics
HRTX
$207M
$5.32M 2.55% 405,901 – –
CHRS icon
11
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$3.65M 1.75% 129,629 – –
STML
12
DELISTED
Stemline Therapeutics, Inc.
STML
$3.38M 1.62% 315,980 – –
ARCT icon
13
Arcturus Therapeutics
ARCT
$462M
$3.23M 1.55% 1,537,463 – –
ORKA
14
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$3.08M 1.47% 1,078,932 – –
AKTX
15
Akari Therapeutics
AKTX
$24.8M
$2.6M 1.25% 369,490 – –
OCRX
16
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.56M 1.23% 1,217,872 +129,500 +12% +$272K
LPCN icon
17
Lipocine
LPCN
$15.8M
$1.55M 0.74% 420,000 – –
SYRE icon
18
Spyre Therapeutics
SYRE
$996M
$1.52M 0.73% 350,133 – –
KALV icon
19
KalVista Pharmaceuticals
KALV
$678M
$1.32M 0.63% +221,651 New +$1.32M
ADVM icon
20
Adverum Biotechnologies
ADVM
$64.6M
$812K 0.39% 280,000 – –
SRRA
21
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$195K 0.09% 130,798 – –
LRMR icon
22
Larimar Therapeutics
LRMR
$310M
– – -141,479 Closed -$468K
RGNX icon
23
Regenxbio
RGNX
$451M
– – -332,494 Closed -$4.66M
ONC
24
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
– – -119,000 Closed -$3.67M
ACHN
25
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
– – -420,000 Closed -$3.4M